Discordance Between Antibody and T Cell Responses in Recipients of Trivalent Inactivated Influenza Vaccine

Vaccine- Netherlands

doi 10.1016/j.vaccine.2008.02.024

Full Text

Abstract

Available in

Date

April 1, 2008

Authors

Publisher

Elsevier BV

Related search

Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine

English

Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children

English

Shedding of Live Vaccine Virus, Comparative Safety, and Influenza-Specific Antibody Responses After Administration of Live Attenuated and Inactivated Trivalent Influenza Vaccines to HIV-infected Children

English

538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine

English

Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink

Archives of Pediatrics & Adolescent Medicine

2011

English

Induction of CD4+ T-Cell-Independent Immunoglobulin Responses by Inactivated Influenza Virus

English

Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost

Contemporary Clinical Trials

Medicine

Pharmacology

2015

English

Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children With Recurrent Wheezing

Clinical and Vaccine Immunology

Medicine

Immunology

Allergy

Clinical Biochemistry

Microbiology

2013

English

Trivalent Inactivated Influenza Vaccine Effective Against Influenza A(H3N2) Variant Viruses in Children During the 2014/15 Season, Japan

English

Amanote Research

Discordance Between Antibody and T Cell Responses in Recipients of Trivalent Inactivated Influenza Vaccine

Vaccine- Netherlands

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine

Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children

Shedding of Live Vaccine Virus, Comparative Safety, and Influenza-Specific Antibody Responses After Administration of Live Attenuated and Inactivated Trivalent Influenza Vaccines to HIV-infected Children

538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine

Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink

Induction of CD4+ T-Cell-Independent Immunoglobulin Responses by Inactivated Influenza Virus

Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost

Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children With Recurrent Wheezing

Trivalent Inactivated Influenza Vaccine Effective Against Influenza A(H3N2) Variant Viruses in Children During the 2014/15 Season, Japan